ENDRA Life Sciences Inc. Common Stock NDRA
$5.87
+4.45%
at last close
Market Cap$8.43 million
P/E Ratio—
Div Yield—
Volume25.5K
52-Week Range
$2.96$9.85
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $25.00 (+325.9% upside)
Key Stats
- Today's Range
- $5.50 – $5.90
- 50-Day Range
- $4.05 – $6.75
- 52-Week Range
- $2.96 – $9.85
- Volume
- 26K shs
- Average Volume
- 36K shs
- Market Cap
- $8.43 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.34
- Price / Sales
- —
Short Interest
- Short Interest
- 0.78%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-5,916,657
- Net Margin
- —
- Return on Equity
- -93.77%
- Debt-to-Equity
- —
About ENDRA Life Sciences Inc. Common Stock
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Related Stocks
Compare head-to-head: NDRA vs MDT·NDRA vs AXGN·NDRA vs BLFS·NDRA vs CNMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.